companydata.dkcompanydata.dk

VACCINIUM HOLDING ApS: Financial statements 2023

CVR: 26474639

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

VACCINIUM HOLDING ApS (CVR 26474639) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -92,198 and a net result of DKK 1,170,737 compared with DKK 2,436,568 the year before. Equity in the 2023 report amounted to DKK 30,515,317. The solvency ratio was 81.4%.

Gross Profit
DKK -92,198
Profit/Loss
DKK 1,170,737
Equity
DKK 30,515,317
Total Assets
DKK 37,494,904

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--92K1.2M30.5M-
2022--170K2.4M49.6M-
2021--191K1.6M168.1M-
2020--480K2.7M112.4M-
2019--47K2.8M149.1M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

VACCINIUM HOLDING ApS: The 2022 annual report is outJul 7, 2023

VACCINIUM HOLDING ApS has published its annual report for 2022. Gross profit came to DKK -170,101, and the net result was DKK 2,436,568.

About VACCINIUM HOLDING ApS

VACCINIUM HOLDING ApS is a Danish company of the type Anpartsselskab based in Rungsted Kyst, founded in 2001. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named KARL KRISTIAN JENSEN ApS. The management consists of Karl Kristian Bergman Jensen. The company is owned by Karl Kristian Bergman Jensen, Bergman Jensen Family Foundation and Louvie Holding S.A.. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -144,218 and a net result of DKK 42,902 compared with DKK -827,704 the year before. Equity in the 2025 report amounted to DKK 36,464,157.

Source: annual report 2025, Danish Business Authority